Latest Integral Health Asset Management, LLC Stock Portfolio
Integral Health Asset Management, LLC Performance:
2024 Q3: 7.36%YTD: 23%2023: 13.73%
Performance for 2024 Q3 is 7.36%, and YTD is 23%, and 2023 is 13.73%.
About Integral Health Asset Management, LLC and 13F Hedge Fund Stock Holdings
Integral Health Asset Management, LLC is a hedge fund based in NEW YORK, NY. On 24-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $656.1 Millions. In it's latest 13F Holdings report, Integral Health Asset Management, LLC reported an equity portfolio of $888.7 Millions as of 30 Sep, 2024.
The top stock holdings of Integral Health Asset Management, LLC are INSM, THC, BSX. The fund has invested 11.9% of it's portfolio in INSMED INC and 9.9% of portfolio in TENET HEALTHCARE CORP.
The fund managers got completely rid off ELEVANCE HEALTH INC (ELV), HUMANA INC (HUM) and UNIVERSAL HLTH SVCS INC (UHS) stocks. They significantly reduced their stock positions in MEREO BIOPHARMA GROUP PLC (MREO), TARSUS PHARMACEUTICALS INC (TARS) and NOVARTIS AG. Integral Health Asset Management, LLC opened new stock positions in INSPIRE MED SYS INC (INSP), MEDTRONIC PLC (MDT) and COOPER COS INC (COO). The fund showed a lot of confidence in some stocks as they added substantially to KEROS THERAPEUTICS INC (KROS), SANA BIOTECHNOLOGY INC (SANA) and CATALYST PHARMACEUTICALS INC (CPRX).
The top stock holdings of Integral Health Asset Management, LLC are INSM, THC, BSX. The fund has invested 11.9% of it's portfolio in INSMED INC and 9.9% of portfolio in TENET HEALTHCARE CORP.
The fund managers got completely rid off ELEVANCE HEALTH INC (ELV), HUMANA INC (HUM) and UNIVERSAL HLTH SVCS INC (UHS) stocks. They significantly reduced their stock positions in MEREO BIOPHARMA GROUP PLC (MREO), TARSUS PHARMACEUTICALS INC (TARS) and NOVARTIS AG. Integral Health Asset Management, LLC opened new stock positions in INSPIRE MED SYS INC (INSP), MEDTRONIC PLC (MDT) and COOPER COS INC (COO). The fund showed a lot of confidence in some stocks as they added substantially to KEROS THERAPEUTICS INC (KROS), SANA BIOTECHNOLOGY INC (SANA) and CATALYST PHARMACEUTICALS INC (CPRX).
Integral Health Asset Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Integral Health Asset Management, LLC made a return of 7.36% in the last quarter. In trailing 12 months, it's portfolio return was 34.07%.
New Buys
| Ticker | $ Bought |
|---|---|
| inspire med sys inc | 33,768,000 |
| medtronic plc | 27,009,000 |
| cooper cos inc | 12,137,400 |
| fresenius medical care ag | 9,585,000 |
| bristol-myers squibb co | 9,054,500 |
| dexcom inc | 8,044,800 |
| brightspring health svcs inc | 7,340,000 |
| alnylam pharmaceuticals inc | 6,875,750 |
New stocks bought by Integral Health Asset Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| keros therapeutics inc | 135 |
| sana biotechnology inc | 50.00 |
| catalyst pharmaceuticals inc | 45.45 |
| regenxbio inc | 34.21 |
| nurix therapeutics inc | 33.33 |
| quest diagnostics inc | 20.00 |
| fate therapeutics inc | 14.71 |
| 89bio inc | 11.11 |
Additions to existing portfolio by Integral Health Asset Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| mereo biopharma group plc | -43.66 |
| tarsus pharmaceuticals inc | -36.44 |
| teleflex incorporated | -33.33 |
| novartis ag | -33.33 |
| scholar rock hldg corp | -31.25 |
| crinetics pharmaceuticals in | -25.00 |
| cytokinetics inc | -25.00 |
| quidelortho corp | -16.67 |
Integral Health Asset Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| relay therapeutics inc | -4,890,000 |
| editas medicine inc | -3,152,250 |
| oscar health inc | -7,910,000 |
| revance therapeutics inc | -1,285,000 |
| elanco animal health inc | -6,493,500 |
| roivant sciences ltd | -4,228,000 |
| denali therapeutics inc | -7,546,500 |
| surgery partners inc | -4,758,000 |
Integral Health Asset Management, LLC got rid off the above stocks
Sector Distribution
Integral Health Asset Management, LLC has about 93% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 93 |
| Others | 7 |
Market Cap. Distribution
Integral Health Asset Management, LLC has about 43.7% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 40 |
| MID-CAP | 32.3 |
| SMALL-CAP | 15 |
| UNALLOCATED | 7.5 |
| MEGA-CAP | 3.7 |
| MICRO-CAP | 1.5 |
Stocks belong to which Index?
About 67% of the stocks held by Integral Health Asset Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 47.6 |
| Others | 33.1 |
| S&P 500 | 19.4 |
Integral Health Asset Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Integral Health Asset Management, LLC
Integral Health Asset Management, LLC has 63 stocks in it's portfolio. About 50.8% of the portfolio is in top 10 stocks. BPMC proved to be the most loss making stock for the portfolio. THC was the most profitable stock for Integral Health Asset Management, LLC last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACLX | arcellx inc | 2.58 | 275,000 | 22,965,200 | unchanged | 0.00 | ||
| AGLE | spyre therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALNY | alnylam pharmaceuticals inc | 0.77 | 25,000 | 6,875,750 | new | |||
| AMGN | amgen inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| APLT | applied therapeutics inc | 0.76 | 800,000 | 6,800,000 | new | |||
| BDX | becton dickinson & co | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BMY | bristol-myers squibb co | 1.02 | 175,000 | 9,054,500 | new | |||
| BPMC | blueprint medicines corp | 3.02 | 290,000 | 26,825,000 | reduced | -14.71 | ||
| BRKR | bruker corp | 1.05 | 135,000 | 9,323,100 | added | 3.85 | ||
| BSX | boston scientific corp | 5.19 | 550,000 | 46,090,000 | reduced | -15.38 | ||
| CABA | cabaletta bio inc | 0.24 | 450,000 | 2,124,000 | added | 5.88 | ||
| CI | the cigna group | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| COO | cooper cos inc | 1.37 | 110,000 | 12,137,400 | new | |||
| CPRX | catalyst pharmaceuticals inc | 0.90 | 400,000 | 7,952,000 | added | 45.45 | ||
| CRBP | corbus pharmaceuticals hldgs | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CRNX | crinetics pharmaceuticals in | 1.73 | 300,000 | 15,330,000 | reduced | -25.00 | ||
| CRSP | crispr therapeutics ag | 0.79 | 150,000 | 7,047,000 | unchanged | 0.00 | ||
| CYTK | cytokinetics inc | 4.46 | 750,000 | 39,600,000 | reduced | -25.00 | ||
| DGX | quest diagnostics inc | 2.10 | 120,000 | 18,630,000 | added | 20.00 | ||
| DNLI | denali therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||